MENU

JDRF-funded researchers have announced that pregnant women living with type 1 diabetes who used a continuous glucose monitor, or CGM, during their pregnancy in a major trial had better blood glucose control and healthier babies. The international trial, named CONCEPTT, is the first study to show the benefits of CGM use on non-glycaemic health outcomes during pregnancy.

Share
Rising stars of research tackle second leadership workshop
Published on October 18, 2017

Have you been following the journey of the JDRF/Macquarie Group Foundation Future Research Leaders Pilot Program? Seven of the best and brightest rising stars of type 1 diabetes research are part of the pilot and in September they came together for a second intensive two-day leadership workshop. Management consultancy, Marlow Hampshire, and career and capability […]

Share
PEAK Program says exercise and T1D can go hand-in-hand
Published on October 16, 2017

More than 60 healthcare professionals from around Australia descended upon Canberra recently to participate in the JDRF Type 1 Diabetes Performance in Exercise and Knowledge (PEAK) program. Keynote speakers included Australian type 1 diabetes (T1D) experts Professor Tim Jones, Dr Carmel Smart, Professor Liz Davis, Professor Paul Fournier and Professor Stephen Twigg as well as international […]

Share
JDRF advocates gather to say thanks
Published on October 4, 2017
Research Progress

More than 80 advocates join supporters and the Prime Minister to celebrate a decade of Australian government investment in type 1 diabetes research. On a glorious Sydney day, JDRF supporters and advocates were hosted by the Prime Minister, Malcolm Turnbull at Kirribilli House to mark ten years of federal government support for type one research.

Share
Islet transplantation in Australia: A journey from bench to bedside
Published on September 27, 2017

A decade ago, islet transplantation was just an experimental procedure confined to labs across Australia. Today, thanks to Government support driven by JDRF advocates, islet transplantation has been a reality for a group of eligible adults with type 1 diabetes (T1D), and there are intensive research efforts behind making the procedure even wider-reaching.

Share
Future Research Leaders: Dr Eliana Marino talks to JDRF
Published on July 14, 2017

Dr Eliana Marino is one of our first seven participants in the pilot year of the JDRF/Macquarie Group Foundation Future Research Leaders Program (FRLP). Hailing from Venezuela, the bubbly Dr Marino speaks with exuberance and energy. She sees beyond what’s happening on the laboratory benchtop, to how the type 1 diabetes community will benefit as […]

Share

At the world’s largest diabetes research conference, held last month, JDRF-funded researchers highlighted exciting breakthroughs and vital work that is paving the way to new type 1 diabetes therapies. More than 18,000 physicians, researchers, health care professionals and patient advocates attended the event, which highlights the latest findings in all major areas of the diabetes research […]

Share

An American research team, partly funded by JDRF, have developed a hydrogel material that increased islet survival and function after transplantation in mice. The research, published in Science Advances, used a degradable hydrogel material combined with a protein called vascular endothelial growth factor (VEGF), to stimulate the growth of blood vessels into transplanted cells.

Share
1 2 3 8